Document Classification

Section Type: RESULTS

Text: TC was reduced from (6. 30 0. 86) mmol/L at baseline to (5. 92 0. 75) mmol/L (-6. 03 %, P > 0. 05) at week 3 and (5. 43 0. 77) mmol/L (-13. 8 %, P < 0. 05) at week 6 in treatment group, from (6. 20 0. 76) mmol/L at week 0 to (5. 70 0. 76) mmol/L (-8. 06 %, P < 0. 05) at week 3 and (5. 84 0. 75) mmol/L (-5. 81 %, P < 0. 05) at week 6 in placebo group.